Products Categories
| CAS No.: | 9010-06-4 |
|---|---|
| Name: | SODIUM ALGIN SULFATE |
| Molecular Structure: | |
|
|
|
| Formula: | H2O4S.xNa.xUnspecified |
| Molecular Weight: | 0 |
| Synonyms: | Heparinoid;Sodium polyanhydromannuronic acid sulfate;Paritol;Alginic acid, hydrogen sulfate, sodium salt (9CI);Alginic acid,hydrogen sulfate, sodium salt;Hepinoid;Ateroid; |
- 958254-66-51H-Imidazo[4,5-b]pyridine-2-carboxaldehyde, 1-methyl-, hydrochloride
- 99170-93-1N-Methyl-2-oxazolamine
- 914458-26-7[5-(2-fluorophenyl)-1-pentyl-1H-pyrrol-3-yl]-1-naphthalenyl-Methanone
- 90221-55-92-bromo-5-methylbenzaldehyde
- 97730-31-9(S)-4'-(2-Methylbutyl)Biphenyl-4-Carbonitrile
- 926293-55-26-Bromo-2-methylpyridine-3-carboxaldehyde
- 911112-05-55-Iodo-3-(trifluoromethyl)-2-pyridinamine
- 95789-13-21,3,7-trimethylpurine-2,6-dione
- 956104-42-02-Bromo-5-nitro-3-(trifluoromethyl)pyridine
- 910247-97-11,2,3-Trimethylimidazolium dimethyl phosphate
- Total:38 Page 1 of 1 1
What can I do for you?
Get Best Price
Specification
The Sodium alginate sulfate, with the CAS registry number 9010-06-4, is also known as Heparinoid. What's more, its systematic name is Sodium polyanhydromannuronic acid sulfate. Its classification codes are: (1)Anti-Inflammatory Agents; (2)Anticoagulants; (3)Drug / Therapeutic Agent; (4)Hematologic Agents. This chemical is heparin derivatives. The term has also been used more loosely to include naturally occurring and synthetic highly-sulphated polysaccharides of similar structure. Heparinoid preparations have been used for a wide range of applications including as anticoagulants and anti-inflammatories and they have been claimed to have hypolipidemic properties.
The toxicity data is as follows:
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| mouse | LD50 | intravenous | 1898mg/kg (1898mg/kg) | American Journal of the Medical Sciences. Vol. 216, Pg. 234, 1948. | |
| mouse | LD50 | oral | 17500mg/kg (17500mg/kg) | Kiso to Rinsho. Clinical Report. Vol. 17, Pg. 2539, 1983. | |
| mouse | LD50 | oral | 17500mg/kg (17500mg/kg) | SKIN AND APPENDAGES (SKIN): HAIR: OTHER BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Kiso to Rinsho. Clinical Report. Vol. 17, Pg. 2539, 1983. |
| rat | LD50 | oral | 18100mg/kg (18100mg/kg) | Kiso to Rinsho. Clinical Report. Vol. 17, Pg. 2539, 1983. | |
| rat | LD50 | oral | 18100mg/kg (18100mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD SKIN AND APPENDAGES (SKIN): HAIR: OTHER | Kiso to Rinsho. Clinical Report. Vol. 17, Pg. 2539, 1983. |
| rat | LD50 | subcutaneous | 500mg/kg (500mg/kg) | Kiso to Rinsho. Clinical Report. Vol. 17, Pg. 2539, 1983. | |
| rat | LD50 | subcutaneous | 500mg/kg (500mg/kg) | SENSE ORGANS AND SPECIAL SENSES: LACRIMATION: EYE BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Kiso to Rinsho. Clinical Report. Vol. 17, Pg. 2539, 1983. |